Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors

NCT01401504 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc